Veradigm Issued Patent for Risk Adjustment Method and Apparatus
- Growth stocks lift Nasdaq 3% as Treasury yields ease
- $22 Billion in 'Unrelenting' New Short Positions Were Added Last Week - Citi
- Why is Credit Suisse in Trouble? All You Need to Know
- No Full Capitulation on Wall Street Yet - Bank of America
- FAA Certification of Boeing's (BA) MAX 10 'No Sooner Than Summer 2023' - Reuters
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Veradigm is providing health plans with a patent-protected method to support risk adjustment programs through “Dynamic Intervention Planning”
CHICAGO--(BUSINESS WIRE)-- Veradigm, a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), today announced that its method and apparatus for risk adjustment patent (“Dynamic Intervention Planning”) has been issued by the United States Patent and Trademark Office (USPTO).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220629005232/en/
The patent covers the systems that power Veradigm’s Dynamic Intervention Planning process. These systems enable Veradigm’s clients to find, size, monetize, prioritize, and resolve opportunities across different lines of business.
“Dynamic Intervention Planning can result in a greater risk adjustment lift for our clients. It allows our clients to properly focus their efforts to be more impactful,” says Tom Langan, President and Chief Commercial Officer of Veradigm. “This means less waste, greater precision in revenue projections, and more control over how our clients manage their programs.”
Through this patent, only Veradigm can identify service item management opportunities, ascribe levels of confidence, and size Risk Adjustment Factor points. This Veradigm Network solution can also recommend and prioritize interventions, communicate opportunities for action electronically to external devices, and dynamically update all of this as the health plan member’s data builds and refines over time.
Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms, Veradigm does all of these and more. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Source: Allscripts Healthcare Solutions
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Imaginuity® Promotes Chelsea Navarro to Chief Financial Officer
- ComEd Energy Doctors Offer Energy-Saving Tips for Cold Weather in Time for National Energy Efficiency Day
- AM Best Comments on Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries Following Completion of Change Healthcare Inc. Acquisition
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!